🇺🇸 Intraperitoneal atomization of levobupivacaine. in United States

Intraperitoneal atomization of levobupivacaine. (Intraperitoneal atomization of levobupivacaine.) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intraperitoneal atomization of levobupivacaine. in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intraperitoneal atomization of levobupivacaine. approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intraperitoneal atomization of levobupivacaine. in United States?

University Hospital, Ghent is the originator. The local marketing authorisation holder may differ — check the official source linked above.